Protective Role of Sulforaphane against Multiorgan Toxicity in Rats: An In-vivo and In-vitro Review Study
DOI:
https://doi.org/10.37591/rrjot.v8i1.201Abstract
Sulforaphane [1-isothiocyanate-(4R) -(methylsulfinyl) butane] is a natural dietary isothiocyanate produced by the enzymatic accomplishment of the myrosinase on glucopharanin, a 4-methylsulfinylbutyl glucosinolate contained in cruciferous vegetables such as broccoli, brussel sprouts, and cabbage. Exploring of this compound against various oxidative degenerative diseases such as hepatic, nephro and cardiac diseases is growing because of its anticarcinogenic and cytoprotective properties. In several invivo and invitro experimental paradigms proved SFN and its compounds are having capacity to protects against various xenobiotics induced oxidative stress mediated diseases such as focal cerebral ischemia, lung inflammation, intracerebral hemorrhage, ischemia and reperfusion induced acute cardiac, hepatic, renal failure, and cancer etc. Sulforaphane is an indirect antioxidant compound is able to induce/activate numerous cytoprotective proteins, including antioxidant enzymes, through the Nrf2/ARE pathway. Because, it poses the powerful electrophiles, attributable to the central carbon atom of the -N= C= S group, which reacts readily with sulfur- nitrogen- and oxygen-based respective antioxidant genes such as heme oxygenase-1, NAD(P)H: quinone oxidoreductase, glutathione-S-transferase, gamma-glutamyl cysteine ligase, and glutathione reductase and induced Nrf2 gene for Phase II enzymes. In conclusion, sulforaphane is a promising antioxidant agent that is effective to attenuate oxidative stress and tissue/cell damage in different in-vivo and in-vitro experimental animals.
Keywords: Sulforaphane, Oxidative stress, rats, liver, kidney, heart, ROS
Cite this Article
Thangapandiyan S, Ramesh M, Miltonprabu S et al. Protective role of Sulforaphane against multiorgan toxicity in rats: An In-vivo and In-vitro review study. Research & Reviews: A Journal of Toxicology. 2018; 8(1): 1–8p.
Downloads
Additional Files
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |